Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer (Q84959068)
Jump to navigation
Jump to search
scientific article published on 10 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer |
scientific article published on 10 September 2012 |
Statements
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer (English)
Sören Lehmann
Vladimir J N Bykov
Dina Ali
Ove Andrén
Honar Cherif
Ulf Tidefelt
Bertil Uggla
Jeffrey Yachnin
Gunnar Juliusson
Ali Moshfegh
Christer Paul
Per-Ola Andersson
10 September 2012